Introduction {#sec1}
============

The food-borne pathogen *Campylobacter jejuni* is one of the leading causes of bacterial gastroenteritis worldwide. *Campylobacter* are characterized by a rapid, darting motility, mediated by bipolar flagella, which is essential for virulence. The flagellum comprises a basal body linked to the flagellar filament, which consists of thousands of copies of the flagellin proteins FlaA and FlaB, with FlaA being the major component. Glycosylation of flagellins appears to be essential for flagellar biogenesis, as mutations in Cj1293, encoding a putative UDP-GlcNAc C6-dehydratase/C4-reductase involved in flagellin glycosylation, were aflagellate and nonmotile.([@ref1]) The Cj1293 orthologue in *Campylobacter coli* VC167 was not essential for flagellin glycosylation or flagellin biogenesis but a double mutant in this gene and *ptmD* involved in pseudaminic acid biosynthesis was also aflagellate and nonmotile.([@ref1]) These observations indicate that flagellin glycosylation with pseudaminic acid and derivatives is essential for targeting and/or secretion of flagellin in *C. jejuni* and *C. coli.* More recently, Howard et al.([@ref2]) have demonstrated the importance of specific structural modifications to the flagellin glycoform in the biological fitness of *C. jejuni* in colonization of chickens.

In 2001, Thibault et al.([@ref3]) analyzed intact flagellins from three strains of *C. jejuni* (81−176, NCTC 11168 and OH4384) and one strain of *C. coli* (VC167 T2) by mass spectrometry. They showed that, in each case, the mass of the monomeric glycoprotein was ∼6 kDa greater than that predicted from the primary sequence. Liquid chromatography mass spectrometry (LC−MS) of tryptic peptides of *C. jejuni* 81−176 flagellin FlaA revealed the presence of seven glycopeptides. The nature of the glycans was assigned following collision-induced dissociation (CID) tandem mass spectrometry (MS/MS) of HPLC fractions containing the suspected glycopeptides. The major glycosylation component was pseudaminic acid (Pse5Ac7Ac), with 5-acetamidino pseudaminic acid (Pse5Am7Ac) and 5,7-*N*-(2,3-dihydroxyproprionyl)-pseudaminic acid (Pse5Pr7Pr) also present. Sites of glycosylation were determined by β-elimination reactions and subsequent MS/MS. In total, 19 serine and threonine glycosylation sites were identified on *C. jejuni* 81−176 FlaA. In further work, Thibault and co-workers applied a top-down approach for the identification of glycosylation in *C. jejuni* 81−176 flagellin.([@ref4]) Again, the major glycans were Pse5Ac7Ac and Pse5Am7Ac. In addition, novel glycans, Pse5Am7Ac8GlnAc and Pse5Ac7Ac8OAc, were identified and localized to tryptic peptide \[390−422\]. The exact sites of the novel modification, however, were not determined.

Soo and co-workers([@ref5]) developed a targeted metabolomics approach for the analysis of glycosylation in *C. jejuni* 81−176, confirming the presence of pseudaminic acid and its acetamidino derivative. Cell lysates were investigated for the presence of sugar-nucleotide metabolites by combining hydrophilic interaction liquid chromatography (HILIC) with precursor ion scanning mass spectrometry and the structures of the metabolites were confirmed by NMR spectroscopy. The method was subsequently applied to *C. coli* VC167.([@ref6]) In addition to pseudaminic acid, acetamidino legionaminic acid (Leg5Am7Ac) and *N*-methylacetimidoyl legionaminic (Leg5AmNMe7Ac) were identified as flagellar glycans.

Most recently, the metabolomics approach was applied to the analysis of *C. jejuni* 11168 flagellin.([@ref7]) Although 11168 was the first *C. jejuni* strain to have its genome sequenced,([@ref8]) the least is known about its flagellin glycosylation. Moreover, its glycosylation locus is far more complex than either *C. jejuni* 81−176 or *C. coli* VC167. Logan et al.([@ref7]) identified two novel glycans, see Scheme [1](#sch1){ref-type="scheme"}, corresponding to dimethylglyceric acid derivatives of pseudaminic acid and 7-acetamidino pseudaminic acid, hereafter referred to as **I** and **II**, respectively. Tryptic peptide \[204−223\] was shown to be modified by either **I** or **II** but the site(s) of glycosylation were not confirmed. Tryptic peptide \[464−480\] was shown to be modified by **I**. Again, the site of modification was not localized. Hitchen et al.([@ref9]) used a 'knock-in' approach to demonstrate that gene Cj1295 is responsible for the presence of the dimethylglyceric acid derivative of pseudaminic acid.

![Structures of **I** and **II**](pr-2010-01021c_0003){#sch1}

Here, we have applied on-line reversed-phase liquid chromatography electron capture dissociation (ECD) tandem mass spectrometry([@ref10]) to the characterization of glycosylation of flagellin A from *C. jejuni* 11168. ECD^[@ref11]−[@ref13]^ is a radically driven fragmentation technique which results in cleavage of the peptide backbone N−Cα to produce *c* and *z*• (or c• and z) fragments. Unlike the more commonly used collision-induced dissociation (CID), labile post-translational modifications, such as glycosylation, are retained on the peptide backbone fragments following ECD.^[@ref14],[@ref15]^ It is possible, therefore, to localize sites of modification unambiguously. We show that flagellin A is glycosylated by **I** at Ser181, Ser207 and either Thr464 or Thr465, and by **II** at Ser181 and Ser207. Glycosylation of Ser181 of flagellin A from *C. jejuni* 11168 has not been observed previously, although LC−MS/MS analysis of flagellins from the knockout strain 11168 Cj1295::aphA and the 'knock-in' strain 111168 Cj1295::aphA cmCj1295 revealed the tryptic peptide \[179−190\] to be modified.([@ref9]) Interestingly, both Ser181 and Ser207 fall within the sequence motif I**[S]{.ul}**TS (**[S]{.ul}** is modified) suggesting the possibility of a consensus sequence for targeting of glycosylation. The equivalent site (also Ser207) has been shown to be modified by the glycans Pse5Ac7Ac and Pse5Am7Ac in flagellin A from *C. jejuni* strain 81−176.([@ref3]) Finally, ECD revealed that flagellin A is glycosylated by **I** at Thr464 or Thr465. The equivalent residues in flagellin A from *C. jejuni* strain 81−176 have not been observed to be glycosylated.([@ref3]) There was no evidence for modification of these residues by glycan **II**. Additionally, there was no evidence for the modification of flagellin A from strain 11168 by any of the glycans known for other strains of *Campylobacter*, for example, pseudaminic acid, legionaminic acid. For comparison, on-line liquid chromatography collision-induced dissociation tandem mass spectrometry was performed. Although the glycopeptides were observed, it was not possible to localize the sites of modification due to the preferential loss of the glycan modification.

Experimental Section {#sec2}
====================

Preparation of Flagellin A {#sec2.1}
--------------------------

The method was based on that of Power et al.([@ref16]) Cultures were grown in Mueller−Hinton broth for 24 h in an atmosphere of 5% O~2~, 10% CO~2~, and 85% N~2~, with shaking at 37 °C. Cells were recovered from approximately 200 mL of culture by centrifugation at 6000*g* for 20 min at 4 °C and resuspended to a calculated OD of 20. Suspensions were homogenized at 20 500 rpm for 3 min using an Ultra-Turrax T-25 high speed homogenizer (IKA Labortechnik) before removal of cells and debris by centrifugation at 6000*g* for 20 min at 4 °C. The supernatant was then subjected to ultracentrifugation at 100 000*g* for 60 min at 5 °C. The pellet was resuspended in 1% (w/v) sodium dodecyl sulfate in distilled water to solubilize membrane fragments, incubated at 37 °C for 2 h, and again subjected to ultracentrifugation as above. The cycle of SDS washing and ultracentrifugation was repeated three times and purity checked by SDS-PAGE and electron microscopy before suspending in water and ultracentrifugation as above for three more cycles to remove SDS. Flagellar fragments were stored in water at −20 °C until required for analysis.

Flagellar proteins isolated from *C. jejuni* strain 11168 were separated by polyacrylamide gel (12%) electrophoresis and visualized with Coomassie stain R250 (BioRad). Bands with a molecular mass of approximately 60 kDa were cut out of the gel and stored at −20 °C until required for trypsinisation.

Trypsin Digestion {#sec2.2}
-----------------

Digestion was performed by use of a Qiagen 3000 robot (Qiagen Sample & Assay Technologies, German). The gel plugs were destained and dehydrated using pure acetonitrile from J.T. Baker (Philipsburg, NJ) and 100 mM ammonium bicarbonate, (Sigma-Aldrich, St. Louis, MO). Cysteines were reduced with 10 mM dithiothrietol (Sigma-Aldrich, St. Louis, MO) and alkylated with 50 mM iodoacetamide (Sigma-Aldrich, St. Louis, MO). Samples were digested overnight with Trypsin Gold (Promega, Madison, WI), 12.5 ng/μL in 25 mM ammonium bicarbonate, at 37 °C.

Liquid Chromatography Tandem Mass Spectrometry (LC−MS/MS) {#sec2.3}
---------------------------------------------------------

On-line reversed-phase liquid chromatography was performed using a Micro AS autosampler and Surveyor MS pump (Thermo Fisher Scientific, Germany). Peptides were separated using a binary solvent system consisting of (A) water (J.T. Baker, Holland) and 0.1% formic acid and (B) acetonitrile (J.T. Baker, Holland) and 0.1% formic acid. Peptides were loaded onto a 75 μm (internal diameter) Integrafrit (New Objective) C8 resolving column (length 10 cm) and separated over a linear 40 min gradient from 5% to 40% (B). Peptides eluted directly (∼300 nL min^−1^) via a TriVersa Nanomate nanospray source (Advion, NY) into a 7 T LTQ FT mass spectrometer (Thermo Fisher Scientific).

### ECD {#sec2.3.1}

The mass spectrometer alternated between a full FT-MS scan (*m*/*z* 380−2000) and a subsequent ECD MS/MS scan of the most abundant ions. Survey scans were acquired in the ICR cell with a resolution of 100 000 at *m*/*z* 400. Precursor ions were isolated in the ion trap and transferred to the ICR cell. Isolation width was 6 *m*/*z* and only multiply charged precursor ions were selected for MS/MS. Dynamic exclusion was used with a repeat count of 1 and exclusion duration of 180 s. Automatic gain control (AGC) was used to accumulate sufficient precursor ions (target value 1 × 10^6^, maximum fill time 4 s). The electrons for ECD were produced by an indirectly heated barium tungsten cylindrical dispenser cathode (5.1 mm diameter, 154 mm from the cell, 1 mm off-axis). The current across the electrode was ∼1.1 A. Ions were irradiated for 60 ms at 5% energy (corresponding to a cathode potential of −2.775 V). ECD mass spectra were acquired with a resolution of 25 000 at *m*/*z* 400. Each ECD scan comprised 6 co-added microscans.

### CID {#sec2.3.2}

The mass spectrometer alternated between a full FT-MS scan (*m*/*z* 380−2000) and subsequent CID MS/MS scans of the three most abundant ions. Survey scans were acquired in the ICR cell with a resolution of 100 000 at *m*/*z* 400. Precursor ions were isolated and subjected to CID in the linear ion trap. Automatic gain control (AGC) was used to accumulate sufficient precursor ions (target value 5 × 10^5^, maximum fill time 200 ms). Collisional activation was performed using helium gas at normalized collision energy 35% and *q*~excite~ = 0.25. The width of the precursor isolation window was 2 *m*/*z* and only multiply charged precursor ions were selected for MS/MS. Dynamic exclusion was used with a repeat count of 1 and exclusion duration of 180 s. Each CID scan comprised three co-added microscans.

Data acquisition was controlled by Xcalibur 2.0 software.

Data Analysis {#sec2.4}
-------------

Data were analyzed manually using Xcalibur 2.1 software (Thermo Fisher Scientific). *In silico* digests were generated by use of ProteinProspector v5.6.1 (<http://prospector.ucsf.edu/prospector/mshome.htm>) (University of California, San Francisco).

Results and Discussion {#sec3}
======================

The tryptic digests of the flagellin A isolated from *C. jejuni* 11168 were analyzed in duplicate by LC-ECD-MS/MS. The data were analyzed manually by comparison with an *in silico* digest of flagellin A. The *in silico* digest included methionine oxidation and asparagine/glutamine deamidation as variable modifications. In addition, the data were searched for the presence of possible glycopeptides. The following potential glycans were considered: **I** (Δ*m* 390.1638, C~16~H~26~N~2~O~9~); **II** (Δ*m* 389.1798, C~16~H~27~N~3~O~8~); multiples and combinations of **I** and **II**, up to two glycans; pseudaminic acid, Pse5Ac7Ac (Δ*m* 316.1270, C~13~H~20~N~2~O~7~); acetamidino pseudaminic acid, Pse5Am7Ac (Δ*m* 315.1430, C~13~H~21~N~3~O~6~); Pse5Pr7Pr (Δ*m* 408.1380, C~15~H~24~N~2~O~11~); Pse5Am7Ac8GlnAc (Δ*m* 485.2122, C~20~H~31~N~5~O~9~); Pse5Ac7Ac8OAc (Δ*m* 358.1376, C~15~H~22~N~2~O~8~); Pse5Ac7Ac8GlnAc (Δ*m* 486.1962, C~20~H~30~N~4~O~10~); Leg5Am7Ac (Δ*m* 315.1430, C~13~H~21~N~3~O~6~) \[Note: this glycan has the same mass shift as acetamidino pseudaminic acid and the two are indistinguishable by the present methodology\]; and Leg5AmNme7Ac (Δ*m* 329.1587, C~14~H~23~N~3~O~6~).

Figure [1](#fig1){ref-type="fig"} shows the sequence coverage obtained (68.4%) following LC-ECD-MS/MS of flagellin. Twenty-nine unmodified peptides and five glycopeptides were observed in various charge states. Unmodified analogues of the glycopeptides were not observed in any case. Three peptides were modified by **I** and two peptides were modified by **II**. Figure [2](#fig2){ref-type="fig"}a shows the ECD mass spectrum of triply charged ions of the tryptic peptide FETGGRISTSGEVQFTLK \[174−191\] modified by **I**, recorded at retention time 41.68 min. The measured monoisotopic *m*/*z* was 783.0605 (*m*/*z*~calc~ 783.0602, Δ 0.4 ppm). (The isolated precursor, shown in Figure [2](#fig2){ref-type="fig"}a inset, also shows a minor peak corresponding to the glycopeptides modified with **II**). Complete sequence coverage was obtained for this glycopeptide, see Figure [2](#fig2){ref-type="fig"}a inset. The peptide contains five possible sites of O-glycosylation (Ser/Thr). As labile modifications are retained on the peptide backbone fragments following ECD, the glycosylation site can be confirmed unequivocally as Ser181. There was no evidence for glycosylation at Thr176, Thr182, Ser183, or Thr189. For comparison, the CID mass spectrum of the \[M + 3H\]^3+^ ions of the **I**-modified glycopeptide is shown in Figure [2](#fig2){ref-type="fig"}b. The dominant fragment peak in that spectrum corresponds to the loss of the glycan from the doubly charged precursor peptide (the Y~0~^2+^ fragment according to Domon and Costello's nomenclature([@ref17])). Only two backbone fragments were observed: *b*~16~ and *b*~17~. It is not possible to assign the site of glycosylation from these fragments.

![Protein sequence coverage obtained following LC-ECD-MS/MS analysis of tryptic digest of flagellin A from *C. jejuni* 11168. Identified peptides are shown in inverse bold.](pr-2010-01021c_0006){#fig1}

![(a) ECD mass spectrum of 3+ ions of **I**-modified glycopeptide FETGGRISTSGEVQFTLK \[174−191\]. Inset: isolated precursor ions showing measured monoisotopic *m*/*z* and peptide sequence coverage obtained. (b) CID mass spectrum of 3+ ions of **I**-modified glycopeptide FETGGRISTSGEVQFTLK \[174−191\]. Inset: peptide sequence coverage obtained.](pr-2010-01021c_0007){#fig2}

The equivalent peptide modified by **II** was observed in the 3+ (*m*/*z*~meas~ 782.7331, *m*/*z*~calc~ 782.7323, Δ 1.0 ppm) and 4+ (*m*/*z*~meas~ 587.3014, *m*/*z*~calc~ 587.3010, Δ 0.7 ppm) charge states. The survey mass spectrum at retention time 40.02 min is shown in Figure [3](#fig3){ref-type="fig"}a. Although both the 3+ and 4+ charge states of this glycopeptides were observed, only the 4+ ions were subjected to ECD. That illustrates one of the disadvantages of ECD, namely, that the relatively long time scale of the ECD event reduces the total number of peptide ions analyzed.([@ref18]) The ECD mass spectrum of the 4+ ions of tryptic peptide FETGGRISTSGEVQFTLK \[174−191\] modified by **II**, recorded at retention time 40.15 min, is shown in Figure [3](#fig3){ref-type="fig"}b. Virtually complete sequence coverage is obtained and it is possible to assign the site of glycosylation as Ser181. Note that cleavage of the N−Cα directly N-terminal of Ser181 residue was not observed. In part that is due to the *m*/*z* of the singly charged *c*~7~ fragment overlapping with the triply charged ion arising from the loss of ammonia, a common and abundant fragment in ECD. Nevertheless, N−Cα cleavages are observed between each of the possible sites of glycosylation allowing unambiguous localization. No evidence for glycosylation at the other serine/threonine residues was obtained. For comparison, the CID mass spectrum of the \[M + 3H\]^3+^ ions of the **II**-modified glycopeptide is shown in Figure [3](#fig3){ref-type="fig"}c. Again, it is not possible to assign the site of glycosylation, nor obtain sequence information, from this mass spectrum.

![(a) Survey FT-ICR mass spectrum obtained at retention time RT = 40.02 min. (b) ECD mass spectrum of 4+ ions of **II**-modified glycopeptide FETGGRISTSGEVQFTLK \[174−191\]. Inset: peptide sequence coverage obtained. (c) CID mass spectrum of 3+ ions of **II**-modified glycopeptide FETGGRISTSGEVQFTLK \[174−191\]. Inset: peptide sequence coverage obtained.](pr-2010-01021c_0008){#fig3}

Ser181 constitutes a novel glycosylation site in flagellin A. The equivalent amino acid residue in flagellin A from *C. jejuni* strain 81−176 is phenylalanine, see Figure [4](#fig4){ref-type="fig"}. Glycosylation so far toward the N-terminus of the flagellin protein has not previously been reported and is potentially significant biologically. First, it questions the likely surface accessibility of glycan residues, previously assumed to be confined to the presumed surface-exposed, less conserved central region of the flagellin.([@ref3]) Second and potentially more significantly, this region of the protein is very close to, if not a part of, the β-hairpin region recently implicated in TLR-5 mediated activation of the innate immune response in mammals when substituted with a Salmonella-derived peptide.([@ref19]) This region may therefore be involved in modulation of host−pathogen interaction at some level.

![Comparison of the O-glycosylation sites identified in flagellin A from *C. jejuni* 81−176([@ref3]) (top, blue typeface) and those identified in flagellin A from *C. jejuni* 11168 in the current study (bottom, black typeface). O-glycosylation sites are shown in red, bold, and underlined.](pr-2010-01021c_0009){#fig4}

The tryptic peptide \[204−223\] VVISTSVGTGLGALADEINK was observed to be glycosylated by both **I** and **II**. Figure [5](#fig5){ref-type="fig"}a shows the ECD mass spectrum of triply charged ions of the tryptic peptide VVISTSVGTGLGALADEINK \[204−223\] modified by **I**, recorded at retention time 47.60 min. The measured monoisotopic *m*/*z* was 778.7485 (*m*/*z*~calc~ 778.7477, Δ 1.0 ppm). The isolated precursor peak, Figure [5](#fig5){ref-type="fig"}a inset, clearly shows that the mass spectrum is obtained from the **I**-modified glycopeptide only, that is, there is no peak corresponding to the **II**-modified glycopeptide at this retention time. Peptide \[204−223\] contains four possible sites of O-glycosylation (two serine and two threonine residues). ECD of the glycopeptide results in complete sequence coverage, that is, all N−Cα are cleaved, and the site of glycosylation is assigned as Ser207. There is no evidence for modification of the remaining serine/threonine residues. The **I**-modified glycopeptide was also observed in low abundance in the 2+ charge state; however, insufficient ions were available for ECD and a single backbone fragment was observed. Figure [5](#fig5){ref-type="fig"}b shows the ECD mass spectrum of triply charged ions of the tryptic peptide VVISTSVGTGLGALADEINK \[204−223\] modified by **II**, recorded at retention time 46.88 min. The measured monisotopic *m*/*z* was 778.4198 (*m*/*z*~calc~ 778.4197, Δ 0.1 ppm), see Figure [5](#fig5){ref-type="fig"}b inset. Again, ECD resulted in complete sequence coverage and the site of glycosylation is confirmed as Ser207. (The dominant fragment observed following CID of the **I**- and **II**-modified \[204−223\] glycopeptide corresponded to loss of the glycan and it was not possible to determine the site of glycosylation from that spectrum (data not shown).)

![(a) ECD mass spectrum of 3+ ions of **I**-modified glycopeptide VVISTSVGTGLGALADEINK \[204−223\]. Inset: isolated precursor ions showing measured monoisotopic *m*/*z* and peptide sequence coverage obtained. (b) ECD mass spectrum of 3+ ions of **II**-modified glycopeptide VVISTSVGTGLGALADEINK \[204−223\]. Inset: isolated precursor ions showing measured monoisotopic *m*/*z* and peptide sequence coverage obtained.](pr-2010-01021c_0001){#fig5}

Glycosylation of the equivalent site in flagellin A, also Ser207, see Figure [4](#fig4){ref-type="fig"}, from *C. jejuni* strain 81−176 has also been observed.([@ref3]) In the case of *C. jejuni* 81−176, the glycans were pseudaminic acid and acetamidino pseudaminic acid, whereas the glycans observed in flagellin A from strain 11168 are the dimethylglyceric acid derivatives. Interestingly, both Ser207 and Ser181 (flagellin A, 11168) fall within the motif I**[S]{.ul}**TS suggesting that a consensus sequence might exist for glycosylation in flagellin A.

Finally, tryptic peptide \[464−480\] (TTAFGVKDETAGVTTLK) was observed to be glycosylated by **I**. There was no evidence for glycosylation of this peptide by glycan **II**. The **I**-glycopeptide was observed in the 3+ charge state with measured monoisotopic *m*/*z* 710.3678 (*m*/*z*~calc~ 710.3669, Δ 1.3 ppm), and the ECD mass spectrum of these ions is shown in Figure [6](#fig6){ref-type="fig"}. There are five potential sites of glycosylation in this peptide, all threonine residues. Virtually complete sequence coverage is obtained, localizing the site of glycosylation to either Thr464 or Thr465. Unfortunately, no N−Cα was observed between these two amino acid residues and it is not possible to confirm absolutely which site (or both) are modified. There was no evidence for glycosylation at the remaining threonine residues. The equivalent residues in flagellin A from *C. jejuni* 81−176 (Thr468 and Thr469, see Figure.[4](#fig4){ref-type="fig"}) have not previously been observed to be modified by any glycan. As in the case of the glycosylation of Ser181, this newly observed glycan-modified residue is located toward the C-terminal end of the known glycosylated, central variable region, but is not the most distal as modification of Thr483 had been observed in the work of Thibault et al.([@ref3])

![ECD mass spectrum of 3+ ions of **I**-modified glycopeptide TTAFGVKDETAGVTTLK \[464−480\]. Inset: isolated precursor ions showing measured monoisotopic *m*/*z* and peptide sequence coverage obtained.](pr-2010-01021c_0002){#fig6}

It is noteworthy that the region identified as heavily glycosylated in flagellin A from *C. jejuni* 81−176([@ref3]) was not detected in the present analysis of the protein from *C. jejuni* 11168. The region contains many serine and threonine residues and it may be that this region is glycosylated in 11168 flagellin A. Three tryptic peptides are predicted from this region: \[339−366\], \[388−420\], and \[421−463\], containing 8, 11, and 14 potential O-glycosylation sites, respectively, all of which have high molecular mass, thus, increasing the likelihood that they will not be observed in the bottom-up LC−MS/MS approach. These peptides were also not observed in the LC-CID-MS/MS analysis. Note that the latter two (388−420 and 421−463) contain the bulk of the glycosylated residues observed by Thibault et al.([@ref3])

Conclusion {#sec4}
==========

We have applied LC-ECD-MS/MS to the analysis of glycosylation of flagellin A from *C. jejuni* 11168. The results confirm the presence of dimethylglyceric acid derivatives of pseudaminic acid and acetamidino pseudaminic acid. The glycosylation sites were assigned as Ser181, Ser207, and Thr464 or Thr465. This work is the first observation of Ser181 as a site of glycosylation. Ser181 was shown to be glycosylated by both **I** and **II**, and this modification may be significant biologically in view of its proximity to a region of the protein that was recently implicated in TLR-5-mediated interaction with the innate immune system. The equivalent amino acid in flagellin A from 81−176 is phenylalanine which clearly cannot be glycosylated. Ser207 was also shown to be glycosylated by both **I** and **II**. The equivalent site in flagellin A from 81−176, also Ser207, has been shown to be glycosylated by pseudaminic acid.([@ref3]) Finally, Thr464 or Thr465 (or both, but exclusively) have been shown to be glycosylated by **I** in flagellin A from 11168. There was no evidence for glycosylation of these residues by **II**. The equivalent sites in flagellin A from 81−176 (Thr468 and Thr469) have not been observed to be modified by any glycan.
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